Latest / The BioHub - by Avetix
Episode 48 - Michael Kauffman- CEO of Nereid Therapeutics
We're honored to have Dr. Michael Kauffman, M.D., Ph.D., the Chief Executive Officer of Nereid Therapeutics, joining us.Dr. Kauffman brings over 25 years of experience in the life sciences industry, with a distinguished track record in oncology drug development. Currently, he leads Nereid Therapeutics, a company at the forefront of pioneering therapies targeting biomolecular condensates—a novel approach to treating complex diseases. Under his leadership, Nereid is advancing multiple programs in oncology and neurodegeneration toward clinical application. PR NewswirePrior to his role at Nereid…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.